Document:

Exhibit 4.4

 Exhibit 4.4 
 WARRANT AGREEMENT 
 Agreement made as of
                    , 2007 between Capitol Acquisition Corp., a Delaware corporation, with offices at 509 7th Street, N.W., Washington, D.C. 20004 (“Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 17 Battery Place, New
York, New York 10004 (“Warrant Agent”). 
 WHEREAS, the Company has received binding commitments (the “Subscription
Agreements”) from Capitol Acquisition Management LLC, an entity controlled by Mark D. Ein, the Company’s Chief Executive Officer, and Raul J. Fernandez and Piyush Sodha, two members of the Company’s board of directors (collectively,
the “Sponsors”) to purchase an aggregate of 7,000,000 warrants to purchase one share of the Company’s common stock, par value $.0001 per share (“Common Stock”) for $7.50, subject to adjustment as described herein
(“Sponsors’ Warrants”); and 
 WHEREAS, the Company is engaged in a public offering (“Public Offering”) of Units
and, in connection therewith, has determined to issue and deliver up to 28,750,000 Warrants (“Public Warrants” and together with the Sponsors’ Warrants, the “Warrants”) to the public investors, each Warrant evidencing the
right of the holder thereof to purchase one share of Common Stock for $7.50, subject to adjustment as described herein; and 
 WHEREAS, the
Company has filed with the Securities and Exchange Commission a Registration Statement on Form S-1, No. 333-144834 (“Registration Statement”), for the registration, under the Securities Act of 1933, as amended (“Act”) of,
among other securities, the Warrants and the Common Stock issuable upon exercise of the Warrants; and 
 WHEREAS, the Company desires the
Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and 
 WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the
respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and 
 WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of
the Company, and to authorize the execution and delivery of this Agreement. 

 NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as
follows: 
 1. Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the
Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement. 
 2.
Warrants. 
 2.1. Form of Warrant. Each Warrant shall be issued in registered form only, shall be in substantially the form of
Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board or President and Treasurer, Secretary or Assistant Secretary of the Company and shall bear a
facsimile of the Company’s seal. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be
issued with the same effect as if he or she had not ceased to be such at the date of issuance. 
 2.2. Effect of Countersignature.
Unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof. 
 2.3. Registration. 
 2.3.1. Warrant
Register. The Warrant Agent shall maintain books (“Warrant Register”), for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue
and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. 
 2.3.2. Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and
treat the person in whose name such Warrant shall be registered upon the Warrant Register (“registered holder”), as the absolute owner of such Warrant 

  

 2 

 
and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on the Warrant Certificate made by anyone other than the
Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. 
 2.4. Detachability of Warrants. The securities comprising the Units will not be separately transferable until 35 days after the date hereof unless
Citigroup Global Markets Inc. (“Citigroup”) informs the Company of its decision to allow earlier separate trading, but in no event will Citigroup allow separate trading of the securities comprising the Units until the Company files a
Current Report on Form 8-K which includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Public Offering including the proceeds received by the Company from the exercise of the Underwriter’s
over-allotment option, if the over-allotment option is exercised prior to the filing of the Form 8-K. 
 2.5 Sponsors’ Warrants.
The Sponsors’ Warrants will be issued in the same form as the Public Warrants but they (i) will not be transferable or salable until the Company completes a business combination (subject to the terms of the Subscription Agreements) and
(ii) will be exercisable on a cashless basis and will be non-redeemable by the Company so long as they are held by the Sponsors or their permitted transferees (as described in the Subscription Agreements). 
 3. Terms and Exercise of Warrants 
 3.1. Warrant
Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the registered holder thereof, subject to the provisions of such Warrant and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock
stated therein, at the price of $7.50 per whole share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Warrant Agreement refers to the
price per share at which Common Stock may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date for a period of not less than 10 business days;
provided, however, that any such reduction shall be identical in percentage terms among all of the Warrants. 
 3.2. Duration of
Warrants. A Warrant may be exercised only during the period (“Exercise Period”) commencing on the later of (i) the consummation by the Company of a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or other similar business combination 

  

 3 

 
(“Business Combination”) (as described more fully in the Company’s Registration Statement) and
(ii)                     , 2008, and terminating at 5:00 p.m., New York City time on the earlier to occur of
(i)                     , 2012 or (ii) the date fixed for redemption of the Warrants as provided in Section 6 of this Agreement
(“Expiration Date”). Except with respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and
all rights in respect thereof under this Agreement shall cease at the close of business on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, however, that the
Company will provide notice to registered holders of the Warrants of such extension of not less than 20 days. 
 3.3. Exercise of
Warrants. 
 3.3.1. Payment. Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant, when countersigned by
the Warrant Agent, may be exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor as Warrant Agent, in the Borough of Manhattan, City and State of New York, with the
subscription form, as set forth in the Warrant, duly executed, and by paying in full the Warrant Price for each full share of Common Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of
the Warrant, as follows: 
 (a) in cash, good certified check or good bank draft payable to the order of the Company (or as otherwise agreed
to by the Company); 
 (b) in the event of redemption pursuant to Section 6 hereof in which the Company’s management has elected to
force all holders of Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares
of Common Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value” by (y) the Fair Market Value. Solely for purposes of this Section 3.3.1(b), the “Fair Market
Value” shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to holders of Warrant pursuant to Section 6
hereof; or 
 (c) with respect to any Sponsors’ Warrants, so long as such Sponsors’ Warrants are held by the 

  

 4 

 
Sponsors or their permitted transferees (as described in the Subscription Agreements), by surrendering such Sponsors’ Warrants for that number of shares
of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the exercise price of the Warrants and the “Fair Market
Value” by (y) the Fair Market Value. Solely for purposes of this Section 3.3.1(c), the “Fair Market Value” shall mean the average last sales price of the Common Stock in the principal trading market for the Common Stock as
reported by any national securities exchange or quoted on the NASD OTC Bulletin Board (or successor exchange), as the case may be, for the five trading days ending on the trading day preceding the date the Sponsors’ Warrants are exercised.

 3.3.2. Issuance of Certificates. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment
of the Warrant Price, the Company shall issue to the registered holder of such Warrant a certificate or certificates for the number of full shares of Common Stock to which he is entitled, registered in such name or names as may be directed by him,
her or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant for the number of shares as to which such Warrant shall not have been exercised. Subject to Section 7.4 and notwithstanding the foregoing, the
Company shall not be obligated to deliver any securities pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Act with respect to the Common Stock issuable upon
exercise of the Warrants is effective and a current prospectus relating to such Common Stock is available, or in the opinion of counsel to the Company, the exercise of the Warrants is exempt from the registration requirements of the Act and such
securities are qualified for sale or exempt from qualification under applicable securities laws of the states or other jurisdictions in which the registered holders reside. For purposes of clarification, in no event will a Sponsors’ Warrant be
exercised unless a registration statement under the Act relating to the Common Stock issuable upon exercise of the Public Warrants is effective and a current prospectus relating to such Common Stock is available. In the event that a registration
statement with respect to the Common Stock underlying a Warrant is not effective under the Act and a current prospectus relating to such Common Stock is not available, the holder of such Warrant shall not be entitled to exercise such Warrant and
such Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle the exercise of the Public Warrants. Warrants may not be exercised by, or securities issued to, any registered holder in any state in
which such exercise would be unlawful. In the event that a registration statement is not effective for the exercised Warrants and a current prospectus relating to such Common Stock is not available, the purchaser of a unit containing such Warrant,
will have paid the full purchase price for the unit solely for the shares included in such unit. 
  

 5 

 3.3.3. Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in
conformity with this Agreement shall be validly issued, fully paid and nonassessable. 
 3.3.4. Date of Issuance. Each person in whose
name any such certificate for shares of Common Stock is issued shall for all purposes be deemed to have become the holder of record of such shares on the date on which the Warrant was surrendered and payment of the Warrant Price was made,
irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares
at the close of business on the next succeeding date on which the stock transfer books are open. 
 3.3.5. Intentionally Omitted. 

 4. Adjustments. 
 The number of shares
of Common Stock issuable upon the exercise of each Warrant is subject to adjustment from time to time upon the occurrence of the events enumerated in this Section 4. For purposes of this Section 4, “Common Stock” means shares now
or hereafter authorized of any class of common stock of the Company and any other stock of the Company, however designated, that has the right (subject to any prior rights of any class or series of preferred stock) to participate in any distribution
of the assets or earnings of the Company without limit as to per share amount. 
 4.1 Adjustment for Change in Capital Stock . If the
Company: 
 (1) pays a dividend or makes a distribution on its Common Stock in either case in shares of its Common Stock;

 (2) subdivides its outstanding shares of Common Stock into a greater number of shares; 
 (3) combines its outstanding shares of Common Stock into a smaller number of shares; 
 (4) makes a distribution on its Common Stock in shares of its capital stock other than Common Stock; or 
 (5) issues by reclassification of its Common Stock any shares of its capital stock, 
 then the number of shares of Common Stock issuable upon exercise of each Warrant immediately prior to such action shall be proportionately adjusted so that the holder of
any Warrant thereafter exercised shall receive the aggregate number and kind of shares of capital stock of the Company which he would have owned immediately following such action if such Warrant had been exercised immediately prior to such action.

 The adjustment shall become effective immediately after the record date in the case of a dividend or distribution and immediately after
the effective date in the case of a subdivision, combination or reclassification. 
 Such adjustment shall be made successively whenever any
event listed above shall occur. 
 4.2 Adjustment for Rights Issue . If the Company distributes any rights, options or warrants to all
holders of its Common Stock entitling them to purchase shares of Common Stock at a price per share less than the Closing Price per share on the Business Day immediately preceding the ex-dividend date for such distribution of rights, options or
warrants, the number of shares of Common Stock issuable upon exercise of each Warrant shall be adjusted in accordance with the formula: 
  

							
		 	N’ = N x	  	      O + A      	  	
		 		  	O + (A x P/M)	  	

 where: 
  

	 	N’ =	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant. 

  

	 	N =	the current number of shares of Common Stock issuable upon exercise of each Warrant. 

  

 6 

	 	O =	the number of shares of Common Stock outstanding on the record date for such distribution. 

  

	 	A =	the number of additional shares of Common Stock issuable pursuant to such rights or warrants. 

  

	 	P =	the purchase price per share of the additional shares. 

  

	 	M =	the Closing Price per share of Common Stock on the record date. 

 The adjustment shall be made successively whenever any such rights, options or warrants are issued and shall become effective immediately after the record date for the determination of stockholders entitled to receive the rights, options or
warrants. If at the end of the period during which such rights, options or warrants are exercisable, not all rights, options or warrants shall have been exercised, the number of shares of Common Stock issuable upon exercise of each Warrant shall be
immediately readjusted to what it would have been if “N” in the above formula had been the number of shares actually issued. 
 4.3
Adjustment for Other Distributions . If the Company distributes to all holders of its Common Stock any of its assets (including cash) or debt securities or any rights, options or warrants to purchase debt securities, assets or other
securities of the Company (other than Common Stock), the number of shares of Common Stock issuable upon exercise of each Warrant shall be adjusted in accordance with the formula: 
  

							
		 	 N’ = N x
	  	   M   	  	
		 		  	M - F	  	

 where: 
  

	 	N’ =	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant. 

  

	 	N =	the current number of shares of Common Stock issuable upon exercise of each Warrant. 

  

	 	M =	the Closing Price per share of Common Stock on the Business Day immediately preceding the ex-dividend date for such distribution. 

  

	 	F =	the fair market value on the ex-dividend date for such distribution of the assets, securities, rights or warrants distributable to one share of Common Stock after taking into
account, in the case of any rights, options or warrants, the consideration required to be paid upon exercise thereof. The Board of Directors shall reasonably determine the fair market value in good faith. 

 The adjustment shall be made successively whenever any such distribution is made and shall become effective immediately after the record date for the
determination of stockholders entitled to receive such distribution. 
 This Section 4.3 does not apply to regular quarterly cash
dividends including increases thereof or rights, options or warrants referred to in Section 4.2. If any adjustment is made pursuant to this Section 4.3 as a result of the issuance of rights, options or warrants and at the end of the period
during which any such rights, options or warrants are exercisable, not all such rights, options or warrants shall have been exercised, the Warrant shall be immediately readjusted as if “F” in the above formula was the fair market value on
the ex-dividend date for such distribution of the indebtedness or assets actually distributed upon exercise of such rights, options or warrants divided by the number of shares of Common Stock outstanding on the ex-dividend date for such
distribution. Notwithstanding anything to the contrary contained in this Section 4.3, if “M-F” in the above formula is less than $1.00, the Company may elect to, and if “M-F” or is a negative number, the Company shall, in
lieu of the adjustment otherwise required by this Section 4.3, distribute to the holders of the Warrants, upon exercise thereof, the evidences of indebtedness, assets, rights, options or warrants (or the proceeds thereof) which would have been
distributed to such holders had such Warrants been exercised immediately prior to the record date for such distribution. 

 4.4 Adjustment for Common Stock Issue . If the Company issues shares of Common Stock for a
consideration per share less than the Closing Price per share on the date the Company fixes the offering price of such additional shares, the number of shares of Common Stock issuable upon exercise of each Warrant shall be adjusted in accordance
with the formula: 
  

							
		 	 N’ = N x
	  	     A     	  	
		 		  	O + P/M	  	

 where: 
  

	 	N’ =	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant. 

  

	 	N =	the current number of shares of Common Stock issuable upon exercise of each Warrant. 

  

	 	O =	the number of shares outstanding immediately prior to the issuance of such additional shares. 

  

	 	P =	the aggregate consideration received for the issuance of such additional shares. 

  

	 	M =	the Closing Price per share on the date of issuance of such additional shares. 

  

	 	A =	the number of shares outstanding immediately after the issuance of such additional shares. 

 The adjustment shall be made successively whenever any such issuance is made, and shall become effective immediately after such issuance. 
 This Section 4.4 does not apply to: 
 (1) any of the transactions described in Sections 4.2 and 4.3, 
 (2) the exercise of
Warrants, or the conversion or exchange of other securities convertible or exchangeable for Common Stock, or the issuance of Common Stock upon the exercise of rights or warrants issued to the holders of Common Stock, 
 (3) Common Stock (and options exercisable therefor) issued to the Company’s employees, officers, directors, consultants or advisors
(whether or not still in such capacity on the date of exercise) under bona fide employee benefit plans or stock option plans adopted by the board of directors of the Company and approved by the holders of Common Stock when required by law, if such
Common Stock would otherwise be covered by this Section 4.4, 
 (4) Common Stock issued in a bona fide public offering
for cash, 
 (5) Common Stock issued in a bona fide private placement to non-affiliates of the Company, including without
limitation the issuance of equity as consideration or partial consideration for acquisitions from persons that are not affiliates of the Company. 
 4.5 Adjustment for Convertible Securities Issue . If the Company issues any securities convertible into or exchangeable for Common Stock (other than securities issued in transactions described in Sections 4.2 and 4.3) for a
consideration per share of Common Stock initially deliverable upon conversion or exchange of such securities less than the Closing Price per share on the date of issuance of such securities, the number of shares of Common Stock issuable upon
exercise of each Warrant shall be adjusted in accordance with this formula: 
  

							
		 	 N’ = N x
	  	    O + D    	  	
		 		  	  O + P/M	  	

 where: 
  

	 	N’ =	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant. 

  

	 	N =	the current number of shares of Common Stock issuable upon exercise of each Warrant. 

  

	 	O =	the number of shares outstanding immediately prior to the issuance of such securities. 

  

	 	P =	the aggregate consideration received for the issuance of such securities. 

  

	 	M =	the Closing Price per share on the date of issuance of such securities. 

  

	 	D =	the maximum number of shares deliverable upon conversion or in exchange for such securities at the initial conversion or exchange rate. 

 The adjustment shall be made successively whenever any such issuance is made, and shall become effective immediately after such issuance. 
 If all of the Common Stock deliverable upon conversion or exchange of such securities have not been issued when such securities are no longer
outstanding, then the number of shares of Common Stock issuable upon exercise of each Warrant shall promptly be readjusted to what it would have been had the adjustment upon the issuance of such securities been made on the basis of the actual number
of shares of Common Stock issued upon conversion or exchange of such securities. 
 This Section 4.5 does not apply to: 
 (1) convertible securities issued in a bona fide public offering for cash; or 
 (2) convertible securities issued in a bona fide private placement to non-affiliates of the Company, including the issuance of convertible
securities as consideration or partial consideration for acquisitions from persons that are not affiliates of the Company. 
 4.6
Adjustment for Tender or Exchange Offer . If the Company or any of its subsidiaries makes a payment in respect of a tender offer or exchange offer for the Common Stock, if the cash and value of any other consideration included in the payment
per share of the Common Stock exceeds the Closing Price of the Common Stock on the trading day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the number of shares of Common Stock
issuable upon exercise of each Warrant will be increased based on the following formula: 
  

							
		 	 N’ = No x
	  	AC + (SP’ x OS’)	  	
		 		  	OSo x SP’	  	

 where, 
  

	 	N’ =	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant; 

  

	 	 No =
	 the current number of shares of Common Stock
issuable upon exercise of each warrant; 

  

	 	AC =	the aggregate value of all cash and any other consideration (as determined by the board of directors of the Company) paid or payable for shares purchased in such tender or exchange
offer; 

  

	 	 Oso =

	 the number of shares of Common
Stock outstanding immediately prior to the date such tender or exchange offer expires; 

  

	 	OS’ =	the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires; and 

	 	SP’ =	the Closing Price of the Common Stock on the trading day next succeeding the date such tender or exchange offer expires. 

 The adjustment shall be made successively and shall become effective immediately following the date such tender or exchange offer expires. 
 4.7 Consideration Received . For purposes of any computation respecting consideration received pursuant to Sections 4.4, 4.5 and 4.6, the
following shall apply: 
 (1) in the case of the issuance of shares of Common Stock for cash, the consideration shall be the
amount of such cash, provided that in no case shall any deduction be made for any commissions, discounts or other expenses incurred by the Company for any underwriting or other sale or disposition of the issue or otherwise in connection therewith;

 (2) in the case of the issuance of shares of Common Stock for a consideration in whole or in part other than cash, the
consideration other than cash shall be deemed to be the fair market value thereof as reasonably determined by the board of directors of the Company (irrespective of the accounting treatment thereof) and described in a board resolution which shall be
filed with the Warrant Agent; and 
 (3) in the case of the issuance of securities convertible into or exchangeable for
shares, the aggregate consideration received therefor shall be deemed to be the consideration received by the Company for the issuance of such securities plus the additional minimum consideration, if any, to be received by the Company upon the
conversion or exchange thereof for the maximum number of shares used to calculate the adjustment (the consideration in each case to be determined in the same manner as provided in clauses (1) and (2) of this Section 4.7). 

4.8 Defined Terms; When De Minimis Adjustment May Be Deferred . As used in this Section 4: 
 (1) The “Closing Price” of the Common Stock on any date of determination means; 
  

	 	(i)	the closing sale price for the regular trading session (without considering after hours or other trading outside regular trading session hours) of the Common Stock (regular way) on
the American Stock Exchange on that date (or, if no closing price is reported, the last reported sale price during that regular trading session), 

  

	 	(ii)	if the Common Stock is not listed for trading on the American Stock Exchange on that date, as reported in the composite transactions for the principal United States securities
exchange on which the Common Stock is so listed, 

  

	 	(iii)	if the Common Stock is not so reported, the last quoted bid price for the Common Stock in the over-the-counter market as reported by the OTC Bulletin Board, the National Quotation
Bureau or similar organization, or 

  

	 	(iv)	if the Common Stock is not so quoted, the average of the mid-point of the last bid and ask prices for the Common Stock from at least three nationally recognized investment banking
firms that the Company selects for this purpose. 

 (2) “ex-dividend date” means the first date on which the shares
of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance or distribution in question; 

 (3) “trading day” means, with respect to the Common Stock or any other security, a day during
which (i) trading in the Common Stock or such other security generally occurs, (ii) there is no market disruption event (as defined below) and (iii) a Closing Price for the Common Stock or such other security (other than a Closing
Price referred to in the next to last clause of such definition) is available for such day; provided that if the Common Stock or such other security is not admitted for trading or quotation on or by any exchange, bureau or other organization,
“trading day” will mean any Business Day; 
 (4) “market disruption event” means, with respect to the Common Stock or any
other security, the occurrence or existence of more than one-half hour period in the aggregate or any scheduled trading day for the Common Stock or such other security of any suspension or limitation imposed on trading (by reason of movements in
price exceeding limits permitted by the stock exchange or otherwise) in the Common Stock or such other security or in any options, contract, or future contracts relating to the Common Stock or such other security, and such suspension or limitation
occurs or exists at any time before 1:00 p.m. (New York time) on such day; and 
 (5) “Business Day” means, any day on which the
American Stock Exchange is open for trading and which is not a Saturday, a Sunday or any other day on which banks in the City of New York, New York, are authorized or required by law to close. 
 No adjustment in the number of shares of Common Stock issuable upon exercise of each Warrant need be made unless the adjustment would require an increase
or decrease of at least 1% in such number. Any adjustments that are not made shall be carried forward and taken into account in any subsequent adjustment. 
 All calculations under this Section 4 shall be made to the nearest cent or to the nearest 1/100th of a share, as the case may be. 
 4.9 When No Adjustment Required . No adjustment need be made for a transaction referred to in Sections 4.2, 4.3, 4.4, 4.5 or 4.6 if Warrant holders are to participate, without requiring the Warrants to be
exercised, in the transaction on a basis and with notice that the board of directors of the Company reasonably determines to be fair and appropriate in light of the basis and notice on which holders of Common Stock participate in the transaction.

 No adjustment need be made for a change in the par value or no par value of the Common Stock. 
 To the extent the Warrants become convertible into cash, no adjustment need be made thereafter as to the amount of cash into which such Warrants are
exercisable. Interest will not accrue on the cash. 
 4.10 Notice of Adjustment . Whenever the number of shares of Common Stock
issuable upon exercise of each Warrant is adjusted, the Company shall provide the notices required by Section 4.19 hereof. 
 4.11
Notice of Certain Transactions . If: 
 (1) the Company takes any action that would require an adjustment in the
Warrant Price pursuant to Sections 4.1, 4.2, 4.3, 4.4, 4.5 or 4.6 and if the Company does not arrange for Warrant holders to participate pursuant to Section 4.9; 
 (2) the Company takes any action that would require a supplemental Warrant Agreement pursuant to Section 4.12; or 
 (3) there is a liquidation or dissolution of the Company, 

 the Company shall mail to Warrant holders a notice stating the proposed record date for a dividend or distribution or the
proposed effective date of a subdivision, combination, reclassification, consolidation, merger, transfer, lease, liquidation or dissolution. The Company shall mail the notice at least 15 days before such date. Failure to mail the notice or any
defect in it shall not affect the validity of the transaction. 
 4.12 Reorganization of Company . If the Company consolidates or
merges with or into, or transfers or leases all or substantially all its assets to, any person, upon consummation of such transaction the Warrants shall automatically become exercisable for the kind and amount of securities, cash or other assets
which the holder of a Warrant would have owned immediately after the consolidation, merger, transfer or lease if such holder had exercised the Warrant immediately before the effective date of the transaction; provided that (i) if the
holders of Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which
each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of Common Stock in such consolidation or merger that affirmatively make such election or (ii) if a tender
or exchange offer shall have been made to and accepted by the holders of Common Stock under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule
13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or
associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the outstanding shares of Common Stock, the holder of a Warrant shall be entitled to receive the highest amount of cash, securities or
other property to which such holder would actually have been entitled as a shareholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by
such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this
Section 4. Concurrently with the consummation of any such transaction, the corporation or other entity formed by or surviving any such consolidation or merger if other than the Company, or the person to which such sale or conveyance shall have
been made, shall enter into a supplemental Warrant Agreement so providing and further providing for adjustments which shall be as nearly equivalent as may be practical to the adjustments provided for in this Section 4. The successor Company
shall mail to Warrant holders a notice describing the supplemental Warrant Agreement. 
 If the issuer of securities deliverable upon
exercise of Warrants under the supplemental Warrant Agreement is an affiliate of the formed, surviving, transferee or lessee corporation, that issuer shall join in the supplemental Warrant Agreement. 
 If this Section 4.12 applies, Sections 4.1, 4.2, 4.3, 4.4, 4.5 and 4.6 do not apply. 
 4.13 Warrant Agent’s Disclaimer . The Warrant Agent has no duty to determine when an adjustment under this Section 4 should be made, how
it should be made or what it should be. The Warrant Agent has no duty to determine whether any provisions of a supplemental Warrant Agreement under Section 4.12 are correct. The Warrant Agent makes no representation as to the validity or value
of any securities or assets issued upon exercise of Warrants. The Warrant Agent shall not be responsible for the Company’s failure to comply with this Section 4. 
 4.14 When Issuance or Payment May Be Deferred . In any case in which this Section 4 shall require that an adjustment in the number of shares
of Common Stock issuable upon exercise of each Warrant be made effective as of a record date for a specified event, the Company may elect to defer until the occurrence of such event (i) issuing to the holder of any Warrant exercised after such
record date the Warrant Shares and other capital stock of the Company, if any, issuable upon such exercise over and above the Warrant Shares and other capital stock of the Company, if any, issuable upon such exercise on the basis of the number of
shares of Common Stock issuable upon exercise of each Warrant and (ii) paying to such holder any amount in cash in lieu of a fractional share pursuant to Section 4.18 hereof; provided, however, that the Company shall deliver
to such holder a due bill or other appropriate instrument evidencing such holder’s right to receive such additional Warrant Shares, other capital stock and cash upon the occurrence of the event requiring such adjustment. 

 4.15 Adjustment in Warrant Price . Upon each event that provides for an adjustment of the number
of shares of Common Stock issuable upon exercise of each Warrant pursuant to this Section 4, each Warrant outstanding prior to the making of the adjustment shall thereafter have an adjusted Warrant Price (calculated to the nearest ten
millionth) obtained from the following formula: 
  

							
		 	 E’ =E x
	 	 N 	  	
		 		 	N’	  	

 where: 
  

	 	E’ =	the adjusted Warrant Price. 

  

	 	E =	the Warrant Price prior to adjustment. 

  

	 	N’ =	the adjusted number of Warrant Shares issuable upon exercise of a Warrant by payment of the adjusted Warrant Price. 

  

	 	N =	the number of Warrant Shares previously issuable upon exercise of a Warrant by payment of the Warrant Price prior to adjustment. 

 Following any adjustment to the Warrant Price pursuant to this Section 4, the amount payable, when adjusted and together with any consideration
allocated to the issuance of the Warrants, shall never be less than the par value per Warrant Share at the time of such adjustment. Such adjustment shall be made successively whenever any event listed above shall occur. 
 4.16 Form of Warrants . Irrespective of any adjustments in the number or kind of shares issuable upon the exercise of the Warrants or the Warrant
Price, Warrants theretofore or thereafter issued may continue to express the same number and kind of shares and Warrant Price as are stated in the Warrants initially issuable pursuant to this Agreement. 
 4.17 Other Dilutive Events . In case any event shall occur affecting the Company, as to which the provisions of this Section 4 are not
strictly applicable, but would impact the holders of Warrants adversely as compared to holders of Common Stock, and the failure to make any adjustment would not fairly protect the purchase rights represented by the Warrants in accordance with the
essential intent and principles of this Section then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing which shall give their opinion
upon the adjustment, if any, on a basis consistent with the essential intent and principles established in this Section 4, necessary to preserve, without dilution, the purchase rights represented by the Warrants. 
 4.18 Fractional Interests. The Company shall not be required to issue fractional shares of Common Stock on the exercise of Warrants. If more than
one Warrant shall be presented for exercise in full at the same time by the same holder, the number of full shares of Common Stock which shall be issuable upon the exercise thereof shall be computed on the basis of the aggregate number of shares of
Common Stock purchasable on exercise of the Warrants so presented. If any fraction of a shares of Common Stock would, except for the provisions of this Section 4.18, be issuable on the exercise of any Warrants (or specified portion thereof),
the Company shall pay an amount in cash equal to the fair market value on the day immediately preceding the date the Warrant is presented for exercise, multiplied by such fraction. 
 4.19 Notices to Warrant Holders. Upon any adjustment of the Warrant Price pursuant to Section 4, the Company shall promptly thereafter, and
in any event within five days, (i) cause to be filed with the Warrant Agent a certificate executed by the Chief Financial Officer of the Company setting forth the number of shares of Common Stock issuable upon exercise of each Warrant after
such adjustment and 

 
setting forth in reasonable detail the method of calculation and the facts upon which such calculations are based, and (ii) cause to be given to each of
the registered holders of the Warrant Certificates at his address appearing on the Warrant register written notice of such adjustments by first-class mail, postage prepaid. Where appropriate, such notice may be given in advance and included as a
part of the notice required to be mailed under the other provisions of this Section 4.19. The Warrant Agent shall be fully protected in relying on any such certificate and on any adjustment therein contained and shall not be deemed to have
knowledge of such adjustment unless and until it shall have received such certificate. 
 In case: 
 (a) the Company shall authorize the issuance to all holders of shares of Common Stock of rights, options or warrants to subscribe for or purchase shares
of Common Stock or of any other subscription rights or warrants; or 
 (b) the Company shall authorize the distribution to all holders of
shares of Common Stock of evidences of its indebtedness or assets (other than regular cash dividends or dividends payable in shares of Common Stock or distributions referred to in Section 4.2 hereof); or 
 (c) of any consolidation or merger to which the Company is a party and for which approval of any shareholders of the Company is required, or of the
conveyance or transfer of the properties and assets of the Company substantially as an entirety, or of any reclassification or change of Common Stock issuable upon exercise of the Warrants (other than a change in par value, or from par value to no
par value, or from no par value to par value, or as a result of a subdivision or combination), or a tender offer or exchange offer for shares of Common Stock; or 
 (d) of the voluntary or involuntary dissolution, liquidation or winding up of the Company; or 
 (e) the
Company proposes to take any action not specified above which would require an adjustment of the Warrant Price pursuant to Section 4 hereof; 
 then the
Company shall cause to be filed with the Warrant Agent and shall cause to be given to each of the registered holders of the Warrant Certificates at his address appearing on the Warrant register, at least 10 calendar days prior to the applicable
record date hereinafter specified, or as promptly as practicable under the circumstances in the case of events for which there is no record date, by first-class mail, postage prepaid, a written notice stating (i) the date as of which the
holders of record of shares of Common Stock to be entitled to receive any such rights, options, warrants or distribution are to be determined, or (ii) the initial expiration date set forth in any tender offer or exchange offer for shares of
Common Stock, or (iii) the date on which any such consolidation, merger, conveyance, transfer, dissolution, liquidation or winding up is expected to become effective or consummated, and the date as of which it is expected that holders of record
of shares of Common Stock shall be entitled to exchange such shares for securities or other property, if any, deliverable upon such reclassification, consolidation, merger, conveyance, transfer, dissolution, liquidation or winding up. The failure to
give the notice required by this Section 4.19 or any defect therein shall not affect the legality or validity of any distribution, right, option, warrant, consolidation, merger, conveyance, transfer, dissolution, liquidation or winding up, or
the vote upon any action. 
 Nothing contained in this Agreement or in any of the Warrant Certificates shall be construed as conferring upon
the holders thereof the right to vote or to consent or to receive notice as shareholders in respect of the meetings of shareholders or the election of directors of the Company or any other matter, or any rights whatsoever as shareholders of the
Company. 

 5. Transfer and Exchange of Warrants. 
 5.1. Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant
Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of
Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request. 
 5.2. Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or
transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the registered holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that in
the event that a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the Company
stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend. 
 5.3. Fractional
Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the issuance of a warrant certificate for a fraction of a warrant. 
 5.4. Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants. 
 5.5. Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of
this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for
such purpose. 
  

 15 

 6. Redemption. 
 6.1. Redemption. Subject to Section 6.4 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time while they are exercisable and so long as an
effective registration statement covering the shares of common stock issuable upon exercise of the Warrants is current and available throughout the “30-day redemption period” (defined below) and prior to their expiration, at the office of
the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $.01 per Warrant (“Redemption Price”), provided that the last sales price of the Common Stock has been at least $14.25 per share (subject to adjustment in
accordance with Section 4 hereof), on each of twenty (20) trading days within any thirty (30) trading day period ending on the third business day prior to the date on which notice of redemption is given. 
 6.2. Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants, the Company shall fix a date
for the redemption. Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than 30 days prior to the date fixed for redemption (the “30-day redemption period”) to the registered holders of the
Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such
notice. 
 6.3. Exercise After Notice of Redemption. The Warrants may be exercised for cash (or on a “cashless basis” in
accordance with Section 3.3.1 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the time and date fixed for redemption. On and after the redemption
date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price. 
 6.4 Exclusion of Certain Warrants. Any of the Sponsors’ Warrants shall not be redeemable by the Company as long as such Sponsors’ Warrants continue to be held by the Sponsors or their permitted transferees (as described in
the Subscription Agreements). However, once the Sponsors or their permitted transferees transfer such Sponsors’ Warrants, such Sponsors’ Warrants shall then be redeemable by the Company pursuant to Section 6 hereof. 
  

 10 

 7. Other Provisions Relating to Rights of Holders of Warrants. 
 7.1. No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, including the right to participate in any liquidation of the trust account (as described in the Registration Statement), exercise any preemptive rights to vote or
to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter. 
 7.2. Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in
their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall
constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone. 
 7.3. Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of
Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement. 
 7.4.
Registration of Common Stock. The Company agrees that prior to the commencement of the Exercise Period, it shall use its best efforts to file with the Securities and Exchange Commission a post-effective amendment to the Registration
Statement, or a new registration statement, for the registration, under the Act, of, and it shall use its best efforts to take such action as is necessary to qualify for sale, in those states in which the Warrants were initially offered by the
Company, the Common Stock issuable upon exercise of the Warrants. In either case, the Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement until the expiration of
the Warrants in accordance with the provisions of this Agreement. The Warrants shall not be exercisable and the Company shall not be obligated to issue Common Stock unless, at the time a holder seeks to exercise the Warrants, a prospectus relating
to Common Stock issuable upon exercise of the Warrants is current and the Common Stock has been registered or qualified or deemed to be exempt under the securities laws of the state of residence of the holder of the Warrants. The provisions of this
Section 7.4 may not be modified, amended or deleted without the prior written consent of Citigroup. 
  

 11 

 8. Concerning the Warrant Agent and Other Matters. 
 8.1. Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant
Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares. 
 8.2. Resignation, Consolidation, or Merger of Warrant Agent. 
 8.2.1. Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after
giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the
Warrant Agent. If the Company shall fail to make such appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of the Warrant (who shall, with such notice,
submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any
successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and
State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority,
powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the
predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any
successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights,
immunities, duties, and obligations. 
 8.2.2. Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be
appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment. 
  

 12 

 8.2.3. Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may
be merged or with which it may be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act. 

8.3. Fees and Expenses of Warrant Agent. 
 8.3.1. Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent
may reasonably incur in the execution of its duties hereunder. 
 8.3.2. Further Assurances. The Company agrees to perform, execute,
acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the
provisions of this Agreement. 
 8.4. Liability of Warrant Agent. 
 8.4.1. Reliance on Company Statement. Whenever in the performance of its duties under this Warrant Agreement, the Warrant Agent shall deem it
necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed
to be conclusively proved and established by a statement signed by the President or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good
faith by it pursuant to the provisions of this Agreement. 
 8.4.2. Indemnity. The Warrant Agent shall be liable hereunder only for
its own negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything done or omitted by the
Warrant Agent in the execution of this Agreement except as a result of the Warrant Agent’s negligence, willful misconduct, or bad faith. 
  

 13 

 8.4.3. Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of
this Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant;
nor shall it be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any
such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether any
shares of Common Stock will when issued be valid and fully paid and nonassessable. 
 8.5. Acceptance of Agency. The Warrant Agent
hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently
account for, and pay to the Company, all moneys received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of Warrants. 
 9. Miscellaneous Provisions. 
 9.1. Successors. All the covenants and provisions of this Agreement by or for the
benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns. 
 9.2.
Notices. Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight
delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows: 
 Capitol Acquisition Corp. 
 509 7th Street, N.W. 
 Washington, D.C. 20004 
 Attn: Mark D. Ein, Chief Executive Officer 
 Any notice, statement or demand authorized by this Agreement to be given or
made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of
such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows: 
 Continental Stock Transfer & Trust Company 
 17 Battery Place 
 New York, New York 10004 
 Attn: Compliance
Department 
  

 14 

 with a copy in each case to: 
 Graubard Miller 
 The Chrysler Building 
 405 Lexington Avenue 
 New York, New York
10174 
 Attn: David Alan Miller, Esq. 
 Facsimile: (212) 818-8881 
 and 
 Davis Polk & Wardwell 
 450 Lexington Avenue 
 New York, New York 10017 
 Attn: Deanna L.
Kirkpatrick, Esq. 
 Facsimile: (212) 450-3800 
 and 
 Citigroup Global Markets Inc. 
 388 Greenwich Street 
 New York, New York 10013 
 Attn: David Spivak 
 Facsimile:
(212) 723-8871 
 9.3. Applicable law. The validity, interpretation, and performance of this Agreement and of the Warrants shall
be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action,
proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenience forum. Any such process or summons to be served upon the
Company may be served by transmitting a copy thereof by registered or 

  

 15 

 
certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2 hereof. Such mailing shall be deemed
personal service and shall be legal and binding upon the Company in any action, proceeding or claim. 
 9.4. Persons Having Rights under
this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the
registered holders of the Warrants and, for the purposes of Sections 2.5, 6.1, 6.4, 7.4, 9.2 and 9.8 hereof, Citigroup, any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation,
promise, or agreement hereof. Citigroup shall be deemed to be a third-party beneficiary of this Agreement with respect to Sections 2.5, 6.1, 6.4, 7.4, 9.2 and 9.8 hereof. All covenants, conditions, stipulations, promises, and agreements contained in
this Warrant Agreement shall be for the sole and exclusive benefit of the parties hereto (and Citigroup with respect to the Sections 2.5, 6.1, 6.4, 7.4, 9.2 and 9.8 hereof) and their successors and assigns and of the registered holders of the
Warrants. 
 9.5. Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the
office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the registered holder of any Warrant. The Warrant Agent may require any such holder to submit his Warrant for inspection by it. 
 9.6. Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all
purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 
 9.7. Effect
of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall not affect the interpretation thereof. 
 9.8 Amendments. This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective
provision contained herein or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest
of the registered holders. All other modifications or amendments, including any amendment to increase the Warrant Price or shorten the Exercise Period, shall require the written consent of the registered holders of a majority of the then outstanding
Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the registered holders. 
  

 16 

 9.9 Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability
of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that
there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 
  

 17 

 IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year
first above written. 
  

			
	CAPITOL ACQUISITION CORP.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 18Exhibit 10.1

 Exhibit 10.1 
                          , 2007 
 Capitol Acquisition Corp. 
 509 7th Street, N.W. 
 Washington, D.C. 20004

 Citigroup Global Markets Inc. 
 388 Greenwich Street

 New York, New York 10013 
  

	 	Re:	Initial Public Offering 

 Gentlemen: 
 This letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by
and between Capitol Acquisition Corp., a Delaware corporation (the “Company”), and Citigroup Global Markets Inc., as Representative (the “Representative”) of the several Underwriters named in Schedule
I thereto (the “Underwriters”), relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”), each comprised of one share of the
Company’s common stock, par value $0.0001 per share (the “Common Stock”), and one warrant, each warrant exercisable for one share of Common Stock (each, a “Warrant”). Certain capitalized terms
used herein are defined in paragraph 15 hereof. 
 In order to induce the Company and the Underwriters to enter into the Underwriting
Agreement and to proceed with the IPO, and in recognition of the benefit that such IPO will confer upon the undersigned as a stockholder of the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the undersigned hereby agrees with the Company as follows: 
 1. If the Company solicits approval of its stockholders of a
Business Combination, the undersigned will (i) vote all shares of Founders’ Common Stock beneficially owned by him, her or it in accordance with the majority of the votes cast by the holders of the IPO Shares and (ii) vote all other
shares of the Company’s Common Stock that may be beneficially acquired by him, her or it in the IPO, any private placement or in the aftermarket in favor of such Business Combination. 

 2. In the event that the Company fails to consummate a Business Combination within 24 months from the
effective date (“Effective Date”) of the registration statement relating to the IPO, the undersigned will, as promptly as possible, (i) cause the Trust Fund to be liquidated and distributed to the holders of IPO Shares and
(ii) cause the Company to liquidate as soon as reasonably practicable. The undersigned hereby waives any and all right, title, interest or claim of any kind in or to any distribution of the Trust Fund and any remaining net assets of the Company
as a result of such liquidation with respect to his shares of Founders’ Common Stock (“Claim”) and hereby waives any Claim the undersigned may have in the future as a result of, or arising out of, any contracts or agreements with the
Company and will not seek recourse against the Trust Fund for any reason whatsoever. In the event of the liquidation of the Trust Fund, the undersigned agrees to indemnify and hold harmless the Company against any and all loss, liability, claims,
damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether pending or threatened, or any claim whatsoever) which the
Company may become subject as a result of any claim by any vendor or other person who is owed money by the Company for services rendered or products sold or contracted for, or by any target business, but only to the extent necessary to ensure that
such loss, liability, claim, damage or expense does not reduce the amount of funds in the Trust Fund; provided that such indemnity shall not apply (i) if such vendor or prospective target business does not execute a valid and enforceable
agreement waiving any claims against the Trust Fund, or (ii) as to any claims under the Company’s obligation to indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the
“Securities Act”). The undersigned acknowledges and agrees that there will be no distribution from the Trust Fund with respect to any warrants, all rights of which will terminate on the Company’s liquidation. 
 3. In order to minimize potential conflicts of interest which may arise from multiple corporate affiliations, the undersigned has agreed, until the
earliest of the consummation by the Company of a Business Combination, the liquidation of the Company or such time as the undersigned ceases to be an officer, to present to the Company for its consideration, prior to presentation to any other
entity, any business opportunity in excess of approximately $190 million which may reasonably be required to be presented to the Company under Delaware law, subject to any pre-existing fiduciary or contractual obligations the undersigned may have.
Decisions by the Company to release the undersigned to pursue any specific business opportunity will be made solely by a majority of the Company’s disinterested directors. 
 4. The undersigned acknowledges and agrees that prior to entering into (i) a Business Combination with a target business that is, or has been within
the past five years, affiliated with any of the Insiders or special advisors of the Company or their affiliates, including an entity that is either a portfolio company, or has otherwise received a material financial investment from, any private
equity fund or investment company (or an affiliate thereof) that is affiliated with such individuals; or (ii) a Business Combination 

  

 2 

 
where the Company acquires less than 100% of a target business and any of the Insiders or special advisors of the Company or their affiliates acquire the
remaining portion of such target business; such transaction must be approved by a majority of the Company’s disinterested independent directors and the Company must obtain an opinion from an independent investment banking firm that such
Business Combination is fair to the Company’s unaffiliated stockholders from a financial point of view. 
 5. Neither the undersigned,
any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to receive and will not accept any compensation or other cash payment for services rendered to the Company prior to or in connection with the
consummation of the Business Combination; provided that the Company shall be allowed to repay a non-interest bearing loan in an aggregate amount of $95,000 made to the Company by the undersigned to cover the IPO expenses. The undersigned and any
affiliate of the undersigned shall also be entitled to reimbursement from the Company for their out-of-pocket expenses incurred in connection with identifying, investigating and consummating a Business Combination. 
 6. Neither the undersigned, any member of the family of the undersigned, nor any affiliate of the undersigned will be entitled to receive or accept a
finder’s fee or any other compensation in the event the undersigned, any member of the family of the undersigned or any affiliate of the undersigned originates a Business Combination. 
 7. The undersigned will escrow all of his shares of Founders’ Common Stock until one year after the consummation by the Company of a Business
Combination subject to the terms of a Stock Escrow Agreement which the Company will enter into with the undersigned and an escrow agent acceptable to the Company. 
 8. The undersigned agrees that until the Company consummates a Business Combination, the undersigned’s Sponsors’ Warrants will be subject to the transfer restrictions described in the Subscription Agreement
relating to the undersigned’s Sponsors’ Warrants. 
 9. The undersigned agrees to be the Chief Executive Officer, Secretary and
Director of the Company until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company. The undersigned’s biographical information furnished to the Company and Citigroup and attached hereto as
Exhibit A is true and accurate in all respects, does not omit any material information with respect to the undersigned’s background and contains all of the information required to be disclosed pursuant to Item 401 of Regulation S-K,
promulgated under the Securities Act of 1933. The undersigned’s NASD Questionnaire furnished to the Company and Citigroup and annexed as Exhibit B hereto is true and accurate in all respects. The undersigned represents and warrants that:

 (a) he is not subject to, or a respondent in, any legal action for, any injunction, cease-and-desist order or order or stipulation to
desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; 
  

 3 

 (b) he has never been convicted of or pleaded guilty to any crime (i) involving any fraud or
(ii) relating to any financial transaction or handling of funds of another person, or (iii) pertaining to any dealings in any securities and he is not currently a defendant in any such criminal proceeding; and 
 (c) he has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities or commodities
license or registration denied, suspended or revoked. 
 10. The undersigned has full right and power, without violating any agreement by
which he is bound, to enter into this letter agreement and to serve as Chief Executive Officer, Secretary and Director of the Company. 
 11.
The undersigned hereby waives his right to exercise conversion rights with respect to any shares of the Company’s common stock owned or to be owned by the undersigned, directly or indirectly, whether such shares be part of the Founders’
Common Stock or shares purchased by the undersigned in the IPO or in the aftermarket, and agrees that he will not seek conversion with respect to such shares in connection with any vote to approve a Business Combination. 
 12. The undersigned hereby agrees to not propose, or vote in favor of, an amendment to Article Sixth or Seventh of the Company’s Certificate of
Incorporation prior to the consummation of a Business Combination other than an amendment to Article Sixth of the Company’s Certificate of Incorporation in accordance with such Article Sixth thereof. Should such a proposal be put before
stockholders, the undersigned hereby agrees to vote against such proposal. This paragraph may not be modified or amended under any circumstances. 
 13. In the event that the Company does not consummate a Business Combination and must liquidate and its remaining net assets are insufficient to complete such liquidation, the undersigned agrees to advance such funds necessary to complete
such liquidation and agrees not to seek repayment for such expenses. 
 14. This letter agreement shall be governed by and construed and
enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The undersigned hereby (i) agrees that any
action, proceeding or claim against him arising out of or relating in any way to this letter agreement (a “Proceeding”) shall be brought and enforced in the courts of the State of New York of the United States of America for the Southern
District of New York, and irrevocably submits to such 

  

 4 

 
jurisdiction, which jurisdiction shall be exclusive, (ii) waives any objection to such exclusive jurisdiction and that such courts represent an
inconvenient forum and (iii) irrevocably agrees to appoint Graubard Miller as agent for the service of process in the State of New York to receive, for the undersigned and on his behalf, service of process in any Proceeding. If for any reason
such agent is unable to act as such, the undersigned will promptly notify the Company and Citigroup and appoint a substitute agent acceptable to each of the Company and Citigroup within 30 days and nothing in this letter will affect the right of
either party to serve process in any other manner permitted by law. 
 15. As used herein, (i) a “Business Combination” shall
mean a merger, capital stock exchange, asset acquisition or other similar business combination with an operating business; (ii) “Insiders” shall mean all officers, directors and stockholders of the Company immediately prior to the
IPO; (iii) “Founders’ Common Stock” shall mean all of the shares of Common Stock of the Company acquired by an Insider prior to the IPO; (iv) “IPO Shares” shall mean the shares of Common Stock issued in the
Company’s IPO; (v) “Sponsors’ Warrants” shall mean the warrants that are being sold privately by the Company simultaneously with the consummation of the IPO; and (vi) “Trust Fund” shall mean the trust fund
into which a portion of the net proceeds of the Company’s IPO will be deposited. 
 16. The undersigned acknowledges and understands
that the Underwriters and the Company will rely upon the agreements, representations and warranties set forth herein in proceeding with the IPO. Nothing contained herein shall be deemed to render the Underwriters a representative of, or a fiduciary
with respect to, the Company, its stockholders or any creditor or vendor of the Company with respect to the subject matter hereof. 
 17.
This letter agreement shall be binding on the undersigned and such person’s respective successors, heirs, personal representatives and assigns. This letter agreement shall terminate on the earlier of (i) the consummation of a Business
Combination and (ii) the liquidation of the Company; provided, that such termination shall not relieve the undersigned from liability from any breach of this agreement prior to its termination. 
  

	
	Mark Ein
	Print Name of Insider
	
	  

	Signature

  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}]]